Abstract
A series of 4-alkoxy-2',4',6'-trihydroxychalcones have been synthesized and evaluated for their ability to inhibit P-glycoprotein-mediated multidrug resistance (MDR) by direct binding to a purified protein domain containing an ATP-binding site and a modulator-interacting region. The introduction of hydrophobic alkoxy groups at position 4 led to much more active compounds as compared to the parent chalcone. The binding affinity increased as a function of the chain length, up to the octyloxy derivative for which a K(D) of 20 nM was obtained.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors*
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
-
Adenosine Triphosphate / metabolism
-
Animals
-
Binding Sites
-
Chalcone / analogs & derivatives*
-
Chalcone / chemical synthesis
-
Chalcone / pharmacology
-
Drug Evaluation, Preclinical
-
Drug Resistance, Multiple / physiology*
-
In Vitro Techniques
-
Magnetic Resonance Spectroscopy
-
Protein Binding
-
Protein Structure, Tertiary
-
Rabbits
-
Structure-Activity Relationship
Substances
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Chalcone
-
Adenosine Triphosphate